Internal Medicine, Endocrinology, Diabetes, & Metabolism · Willoughby, OH
NPI
1184745143
Since 2007
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
5105 Som Center Rd Ste 106
Willoughby, OH, 44094
Phone (440) 266-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$117K
4,183 services
Medicare patients, 2024
715
Average age 73
Drug cost, 2024
$7.4M
14,275 prescriptions
Company payments, 2025
$298
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian E Burtch was code 99214 (office e&m - established), 1,028 times for 502 patients. In total Brian E Burtch billed 4,183 services in 11 codes, and Medicare paid $117K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-02-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,028 | 502 | $74.68 | $77K |
| 83036 Blood Count | Office | 983 | 477 | $9.50 | $9,337 |
| 95251 Test - Miscellaneous | Office | 412 | 234 | $24.34 | $10K |
| 99213 Office E&M - Established | Office | 270 | 235 | $47.00 | $13K |
| 99204 Office E&M - New | Office | 46 | 46 | $118.26 | $5,440 |
| 99203 Office E&M - New | Office | 28 | 28 | $76.89 | $2,153 |
By year: 2022 $111K for 2,791 services; 2023 $128K for 3,234 services; 2024 $117K for 4,183 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 983 | 477 | $9.50 | $9,337 |
Medicare prescription drug claims, 2024
In 2024, the drug Brian E Burtch prescribed most often to Medicare patients was Ozempic (Semaglutide), with 1,281 prescriptions and refills. In total Brian E Burtch wrote 14,275 Medicare prescriptions that cost $7.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 1,281 | 2,127 | 308 | $2.0M |
| Levothyroxine Sodium Generic | 923 | 2,334 | 280 | $9,480 |
| Metformin Hcl Er Metformin Hcl | 844 | 2,147 | 276 | $9,733 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 621 | 1,551 | 231 | $125K |
| Atorvastatin Calcium Generic | 601 | 1,594 | 203 | $5,812 |
| Mounjaro Tirzepatide | 595 | 817 | 120 | $859K |
| Pioglitazone Hcl Generic | 574 | 1,532 | 181 | $5,868 |
| Trulicity Dulaglutide | 554 | 783 | 121 | $752K |
| Metformin Hcl Generic | 468 | 1,286 | 145 | $4,224 |
| Tresiba Flextouch U-100 Insulin Degludec | 368 | 903 | 134 | $374K |
| Humalog Kwikpen U-100 Insulin Lispro | 359 | 908 | 146 | $176K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 358 | 960 | 153 | $40K |
| Jardiance Empagliflozin | 293 | 622 | 92 | $354K |
| Farxiga Dapagliflozin Propanediol | 285 | 663 | 96 | $364K |
| Glimepiride Generic | 282 | 702 | 97 | $2,641 |
Brand drugs: 6,978 claims; generic drugs: 6,385 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian E Burtch $298 ($298 in general payments such as food, travel and fees) from 5 companies. The largest payer was Novo Nordisk Inc with $102.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.